PHARMA NORD EXPORT ApS: Financial statements 2016
CVR: 70996510
PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 2,239,595 and a net result of DKK 2,739,796 compared with DKK 3,155,255 the year before. That is a decrease of 1.1% compared with the year before. Equity amounted to DKK 62,025,085. The solvency ratio was 80.3%.
- Gross Profit
- 2,239,595 kr.
- Profit/Loss
- 2,739,796 kr.
- Equity
- 62,025,085 kr.
- Total Assets
- 77,245,808 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 2.2 mio. | 2.7 mio. | 62 mio. | - |
| 2015 | - | 2.3 mio. | 3.2 mio. | 59.3 mio. | - |
| 2014 | - | 1.9 mio. | 3.1 mio. | 56.1 mio. | - |
| 2013 | - | 2.3 mio. | 6.3 mio. | 53 mio. | - |
| 2012 | - | 2.3 mio. | 6 mio. | 47.1 mio. | - |
How creditworthy is PHARMA NORD EXPORT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
PHARMA NORD EXPORT ApS has published its annual report for 2015. Gross profit came to DKK 2,264,422, and the net result was DKK 3,155,255.
About PHARMA NORD EXPORT ApS
PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity amounted to DKK 46,928,000.
